Crossmark

Identification and experimental verification of a novel cisplatin resistance-related lncRNA signature for predicting prognosis and immune response in lung adenocarcinoma

Crossref DOI link: https://doi.org/10.1007/s12094-025-04079-6

Published Online: 2025-10-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lv, Minghe https://orcid.org/0000-0001-9342-773X
Tang, Lei

Yang, Liu

Yu, Jingping

Ji, Qing

Zhao, Ruping
Funding

Funding for this research was provided by:

the Shanghai Health Commission (202340160)

Science and technology development project of Shanghai University of Traditional Chinese Medicine (24KFL065)

National Natural Science Foundation of China (82274338)
License Information

Text and Data Mining valid from 2025-10-14

Version of Record valid from 2025-10-14
More Information

Article History

Received: 1 September 2025

Accepted: 26 September 2025

First Online: 14 October 2025

Declarations

:

: The authors declare that there is no competing interest.

: Not applicable.

: All the authors declare their consent to the publication of the article.

Document is current

Any future updates will be listed below